International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 2, pp. 404 - 411
Background Human liver has an unusual sensitivity to radiation that limits its use in cancer therapy or in preconditioning for hepatocyte transplantation....
Radiology | Hematology, Oncology and Palliative Medicine | STEM-CELLS | THERAPY | ONCOLOGY | VENOOCCLUSIVE DISEASE | HEPATECTOMY | BONE-MARROW-TRANSPLANTATION | TERM FOLLOW-UP | AMELIORATION | RADIOTHERAPY | DYSFUNCTION | FULMINANT HEPATIC-FAILURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Liver - pathology | Tomography, Emission-Computed, Single-Photon - methods | Macaca fascicularis | Hepatocytes - pathology | Liver - radiation effects | Liver Failure, Acute - etiology | Male | Albumins - analysis | Radiosurgery - adverse effects | Hepatocytes - radiation effects | Radiation Injuries, Experimental - etiology | Liver - diagnostic imaging | Alkaline Phosphatase - analysis | Dose Fractionation | Hepatic Veno-Occlusive Disease - pathology | Liver - surgery | Disease Models, Animal | Hepatic Veno-Occlusive Disease - diagnostic imaging | Hepatic Veno-Occlusive Disease - etiology | Radiation Injuries, Experimental - diagnostic imaging | Alanine Transaminase - analysis | Radiation Dosage | Radiation Injuries, Experimental - pathology | Hepatocytes - diagnostic imaging | Retreatment | Animals | Body Weight - radiation effects | Primates | Medical colleges | Liver diseases | Nuclear radiation | Health aspects | Analysis | FIBROSIS | RODENTS | NEOPLASMS | LIVER | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | ALKALINE PHOSPHATASE | MONKEYS | RADIATION INJURIES
Radiology | Hematology, Oncology and Palliative Medicine | STEM-CELLS | THERAPY | ONCOLOGY | VENOOCCLUSIVE DISEASE | HEPATECTOMY | BONE-MARROW-TRANSPLANTATION | TERM FOLLOW-UP | AMELIORATION | RADIOTHERAPY | DYSFUNCTION | FULMINANT HEPATIC-FAILURE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Liver - pathology | Tomography, Emission-Computed, Single-Photon - methods | Macaca fascicularis | Hepatocytes - pathology | Liver - radiation effects | Liver Failure, Acute - etiology | Male | Albumins - analysis | Radiosurgery - adverse effects | Hepatocytes - radiation effects | Radiation Injuries, Experimental - etiology | Liver - diagnostic imaging | Alkaline Phosphatase - analysis | Dose Fractionation | Hepatic Veno-Occlusive Disease - pathology | Liver - surgery | Disease Models, Animal | Hepatic Veno-Occlusive Disease - diagnostic imaging | Hepatic Veno-Occlusive Disease - etiology | Radiation Injuries, Experimental - diagnostic imaging | Alanine Transaminase - analysis | Radiation Dosage | Radiation Injuries, Experimental - pathology | Hepatocytes - diagnostic imaging | Retreatment | Animals | Body Weight - radiation effects | Primates | Medical colleges | Liver diseases | Nuclear radiation | Health aspects | Analysis | FIBROSIS | RODENTS | NEOPLASMS | LIVER | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | ALKALINE PHOSPHATASE | MONKEYS | RADIATION INJURIES
Journal Article
Blood, ISSN 0006-4971, 1997, Volume 89, Issue 5, pp. 1501 - 1506
The purpose of this report is to review the Fred Hutchinson Cancer Research Center experience of treating patients with venocclusive disease of the liver (VOD)...
K MA HEMATOLOGY | DEFIBROTIDE | VENOOCCLUSIVE DISEASE | ALTEPLASE | ORTHOTOPIC LIVER-TRANSPLANTATION | RT-PA | PREVENTION | CONTINUOUS INFUSION | PROSTAGLANDIN-E1 | IDENTIFICATION | HEMATOLOGY | RANDOMIZED TRIAL | Hepatic Veno-Occlusive Disease - etiology | Humans | Middle Aged | Child, Preschool | Heparin - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Adolescent | Bone Marrow Transplantation - adverse effects | Adult | Infusions, Intravenous | Child | Hepatic Veno-Occlusive Disease - drug therapy
K MA HEMATOLOGY | DEFIBROTIDE | VENOOCCLUSIVE DISEASE | ALTEPLASE | ORTHOTOPIC LIVER-TRANSPLANTATION | RT-PA | PREVENTION | CONTINUOUS INFUSION | PROSTAGLANDIN-E1 | IDENTIFICATION | HEMATOLOGY | RANDOMIZED TRIAL | Hepatic Veno-Occlusive Disease - etiology | Humans | Middle Aged | Child, Preschool | Heparin - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Adolescent | Bone Marrow Transplantation - adverse effects | Adult | Infusions, Intravenous | Child | Hepatic Veno-Occlusive Disease - drug therapy
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2/2014, Volume 88, Issue 2, pp. 404 - 411
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 07/2016, Volume 51, Issue 7, pp. 906 - 912
Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life threatening complication that can develop after...
VENOCCLUSIVE DISEASE | TISSUE-PLASMINOGEN ACTIVATOR | IMMUNOLOGY | TRANSPLANTATION | HEPATIC VENOOCCLUSIVE-DISEASE | MR-IMAGING FINDINGS | SIGNIFICANT TOXICITY | DEFIBROTIDE | RISK-FACTOR | ONCOLOGY | LIVER | ANTITHROMBIN-III | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Severity of Illness Index | Hepatic Veno-Occlusive Disease - etiology | Humans | Risk Factors | Sensitivity and Specificity | Hematopoietic Stem Cell Transplantation - adverse effects | Biomarkers | Adult | Hepatic Veno-Occlusive Disease - diagnosis | Early Diagnosis | Hepatic Veno-Occlusive Disease - therapy | Blood circulation disorders | Evaluation | Complications and side effects | Practice guidelines (Medicine) | Transplantation | Diagnosis | Medicine, Preventive | Methods | Hematopoietic stem cells | Preventive health services | Special Report
VENOCCLUSIVE DISEASE | TISSUE-PLASMINOGEN ACTIVATOR | IMMUNOLOGY | TRANSPLANTATION | HEPATIC VENOOCCLUSIVE-DISEASE | MR-IMAGING FINDINGS | SIGNIFICANT TOXICITY | DEFIBROTIDE | RISK-FACTOR | ONCOLOGY | LIVER | ANTITHROMBIN-III | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Severity of Illness Index | Hepatic Veno-Occlusive Disease - etiology | Humans | Risk Factors | Sensitivity and Specificity | Hematopoietic Stem Cell Transplantation - adverse effects | Biomarkers | Adult | Hepatic Veno-Occlusive Disease - diagnosis | Early Diagnosis | Hepatic Veno-Occlusive Disease - therapy | Blood circulation disorders | Evaluation | Complications and side effects | Practice guidelines (Medicine) | Transplantation | Diagnosis | Medicine, Preventive | Methods | Hematopoietic stem cells | Preventive health services | Special Report
Journal Article
American Journal of Physiology. Lung Cellular and Molecular Physiology, ISSN 1040-0605, 2012, Volume 302, Issue 4, pp. L363 - L369
Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ. The monocrotaline model of pulmonary hypertension in perspective. Am...
Myocarditis | Acute lung injury | Hepatic venocclusive disease | Monocrotaline | Pulmonary hypertension | CROTALARIA SPECTABILIS | PHYSIOLOGY | pulmonary hypertension | myocarditis | PYRROLIZIDINE ALKALOIDS | monocrotaline | HEART-FAILURE | acute lung injury | ARTERIAL ENDOTHELIAL-CELLS | RESPIRATORY-DISTRESS-SYNDROME | TREATED RATS | CYTOCHROME-P450 3A | HEPATIC VENOOCCLUSIVE DISEASE | RESPIRATORY SYSTEM | hepatic venocclusive disease | RIGHT-VENTRICULAR HYPERTROPHY | VASCULAR CHANGES | Acute Lung Injury - physiopathology | Lung - pathology | Myocarditis - chemically induced | Humans | Hypertension, Pulmonary - physiopathology | Chemical and Drug Induced Liver Injury - physiopathology | Hypertension, Pulmonary - chemically induced | Animals | Acute Lung Injury - chemically induced | Myocarditis - pathology | Chemical and Drug Induced Liver Injury - pathology | Lung - blood supply | Hypertension, Pulmonary - pathology | Myocarditis - physiopathology | Disease Models, Animal | Biomechanics | Physiological aspects | Physiology, Pathological | Development and progression | Research
Myocarditis | Acute lung injury | Hepatic venocclusive disease | Monocrotaline | Pulmonary hypertension | CROTALARIA SPECTABILIS | PHYSIOLOGY | pulmonary hypertension | myocarditis | PYRROLIZIDINE ALKALOIDS | monocrotaline | HEART-FAILURE | acute lung injury | ARTERIAL ENDOTHELIAL-CELLS | RESPIRATORY-DISTRESS-SYNDROME | TREATED RATS | CYTOCHROME-P450 3A | HEPATIC VENOOCCLUSIVE DISEASE | RESPIRATORY SYSTEM | hepatic venocclusive disease | RIGHT-VENTRICULAR HYPERTROPHY | VASCULAR CHANGES | Acute Lung Injury - physiopathology | Lung - pathology | Myocarditis - chemically induced | Humans | Hypertension, Pulmonary - physiopathology | Chemical and Drug Induced Liver Injury - physiopathology | Hypertension, Pulmonary - chemically induced | Animals | Acute Lung Injury - chemically induced | Myocarditis - pathology | Chemical and Drug Induced Liver Injury - pathology | Lung - blood supply | Hypertension, Pulmonary - pathology | Myocarditis - physiopathology | Disease Models, Animal | Biomechanics | Physiological aspects | Physiology, Pathological | Development and progression | Research
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 02/2018, Volume 53, Issue 2, pp. 138 - 145
The advances in hematopoietic cell transplantation (HCT) over the last decade have led to a transplant-related mortality below 15%. Hepatic sinusoidal...
VENOCCLUSIVE DISEASE | GEMTUZUMAB OZOGAMICIN EXPOSURE | INTRAVENOUS BUSULFAN | IMMUNOLOGY | MYELOABLATIVE CHEMOTHERAPY | TRANSPLANTATION | ONCOLOGY | HEPATIC VENOOCCLUSIVE DISEASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | DOPPLER-ULTRASONOGRAPHY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HIGH-RISK NEUROBLASTOMA | HEMATOLOGY | Europe | Humans | Risk Factors | Female | Male | Treatment Outcome | Hepatic Veno-Occlusive Disease - classification | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - pathology | Incidence | Usage | Care and treatment | Transplantation | Children | Diagnosis | Hematopoietic stem cells | Diseases | Veno-occlusive disease | Transplants & implants | Mortality | Medical services | Adults | Diagnostic systems | Criteria | Blood | Hemopoiesis | Special Report
VENOCCLUSIVE DISEASE | GEMTUZUMAB OZOGAMICIN EXPOSURE | INTRAVENOUS BUSULFAN | IMMUNOLOGY | MYELOABLATIVE CHEMOTHERAPY | TRANSPLANTATION | ONCOLOGY | HEPATIC VENOOCCLUSIVE DISEASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | DOPPLER-ULTRASONOGRAPHY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HIGH-RISK NEUROBLASTOMA | HEMATOLOGY | Europe | Humans | Risk Factors | Female | Male | Treatment Outcome | Hepatic Veno-Occlusive Disease - classification | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - pathology | Incidence | Usage | Care and treatment | Transplantation | Children | Diagnosis | Hematopoietic stem cells | Diseases | Veno-occlusive disease | Transplants & implants | Mortality | Medical services | Adults | Diagnostic systems | Criteria | Blood | Hemopoiesis | Special Report
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 3, pp. 400 - 409
Abstract Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), can develop in a subset of patients, primarily after...
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Sinusoidal obstruction syndrome | Treatment | Hepatic veno-occlusive disease | Risk factors | Prophylaxis | VENOCCLUSIVE DISEASE | ADULT PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | RANDOMIZED-TRIAL | EUROPEAN GROUP | IMMUNOLOGY | TRANSPLANTATION | URSODEOXYCHOLIC ACID | LIVER | HEMATOLOGY | Severity of Illness Index | Disease-Free Survival | Hepatic Veno-Occlusive Disease - etiology | Allografts | Risk Factors | Hepatic Veno-Occlusive Disease - mortality | Hematopoietic Stem Cell Transplantation | Survival Rate | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - prevention & control | Medical colleges | Transplantation | Mortality | Hematopoietic stem cells | Stem cells
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Sinusoidal obstruction syndrome | Treatment | Hepatic veno-occlusive disease | Risk factors | Prophylaxis | VENOCCLUSIVE DISEASE | ADULT PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | RANDOMIZED-TRIAL | EUROPEAN GROUP | IMMUNOLOGY | TRANSPLANTATION | URSODEOXYCHOLIC ACID | LIVER | HEMATOLOGY | Severity of Illness Index | Disease-Free Survival | Hepatic Veno-Occlusive Disease - etiology | Allografts | Risk Factors | Hepatic Veno-Occlusive Disease - mortality | Hematopoietic Stem Cell Transplantation | Survival Rate | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - prevention & control | Medical colleges | Transplantation | Mortality | Hematopoietic stem cells | Stem cells
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2015, Volume 168, Issue 4, pp. 481 - 491
Summary Sinusoidal obstruction syndrome (SOS), also called veno‐occlusive disease of the liver, is one of the most relevant complications of endothelial origin...
endothelial damage | defibrotide | sinusoidal obstruction syndrome | early complications post‐HCT | veno‐occlusive disease of the liver | Endothelial damage | Sinusoidal obstruction syndrome | Early complications post-HCT | Veno-occlusive disease of the liver | Defibrotide | VENOCCLUSIVE DISEASE | veno-occlusive disease of the liver | REGIMEN-RELATED TOXICITIES | LOW-DOSE HEPARIN | BONE-MARROW-TRANSPLANTATION | RANDOMIZED-TRIAL | early complications post-HCT | PLASMINOGEN-ACTIVATOR | URSODEOXYCHOLIC ACID | HEPATIC VENOOCCLUSIVE DISEASE | ENDOTHELIAL-CELLS | CONTINUOUS-INFUSION | HEMATOLOGY | Fluid Therapy | Hepatic Veno-Occlusive Disease - physiopathology | Diagnosis, Differential | Hepatic Veno-Occlusive Disease - etiology | Methylprednisolone - therapeutic use | Humans | Risk Factors | Symptom Assessment | Hematopoietic Stem Cell Transplantation | Endothelium, Vascular - drug effects | Polydeoxyribonucleotides - therapeutic use | Combined Modality Therapy | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - therapy | Multiple Organ Failure - prevention & control | Multiple Organ Failure - etiology | Endothelium, Vascular - pathology | Transplantation Conditioning - adverse effects | Disease Management | Transplantation Conditioning - methods | Drug Therapy, Combination | Early Diagnosis | Transplantation | Liver diseases | Health aspects | Hematopoietic stem cells
endothelial damage | defibrotide | sinusoidal obstruction syndrome | early complications post‐HCT | veno‐occlusive disease of the liver | Endothelial damage | Sinusoidal obstruction syndrome | Early complications post-HCT | Veno-occlusive disease of the liver | Defibrotide | VENOCCLUSIVE DISEASE | veno-occlusive disease of the liver | REGIMEN-RELATED TOXICITIES | LOW-DOSE HEPARIN | BONE-MARROW-TRANSPLANTATION | RANDOMIZED-TRIAL | early complications post-HCT | PLASMINOGEN-ACTIVATOR | URSODEOXYCHOLIC ACID | HEPATIC VENOOCCLUSIVE DISEASE | ENDOTHELIAL-CELLS | CONTINUOUS-INFUSION | HEMATOLOGY | Fluid Therapy | Hepatic Veno-Occlusive Disease - physiopathology | Diagnosis, Differential | Hepatic Veno-Occlusive Disease - etiology | Methylprednisolone - therapeutic use | Humans | Risk Factors | Symptom Assessment | Hematopoietic Stem Cell Transplantation | Endothelium, Vascular - drug effects | Polydeoxyribonucleotides - therapeutic use | Combined Modality Therapy | Hepatic Veno-Occlusive Disease - diagnosis | Hepatic Veno-Occlusive Disease - therapy | Multiple Organ Failure - prevention & control | Multiple Organ Failure - etiology | Endothelium, Vascular - pathology | Transplantation Conditioning - adverse effects | Disease Management | Transplantation Conditioning - methods | Drug Therapy, Combination | Early Diagnosis | Transplantation | Liver diseases | Health aspects | Hematopoietic stem cells
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 09/2018, Volume 24, Issue 9, pp. 1896 - 1900
Sinusoidal obstruction syndrome (SOS)/hepatic veno-occlusive disease (VOD) is a well-documented complication after hematopoietic stem cell transplantation...
Sinusoidal obstruction syndrome | Color Doppler | Hepatic veno-occlusive disease | Hematopoietic stem cell transplantation | Ultrasonography | VENOCCLUSIVE DISEASE | MULTIORGAN FAILURE | DIAGNOSIS | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | EUROPEAN-SOCIETY | TRANSPLANTATION | HEPATIC VENOOCCLUSIVE DISEASE | LIVER | DOPPLER-ULTRASONOGRAPHY | HEMATOLOGY | MYELOABLATIVE TREATMENT | Transplantation | Ultrasound imaging | Analysis | Hematopoietic stem cells | Stem cells
Sinusoidal obstruction syndrome | Color Doppler | Hepatic veno-occlusive disease | Hematopoietic stem cell transplantation | Ultrasonography | VENOCCLUSIVE DISEASE | MULTIORGAN FAILURE | DIAGNOSIS | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | IMMUNOLOGY | EUROPEAN-SOCIETY | TRANSPLANTATION | HEPATIC VENOOCCLUSIVE DISEASE | LIVER | DOPPLER-ULTRASONOGRAPHY | HEMATOLOGY | MYELOABLATIVE TREATMENT | Transplantation | Ultrasound imaging | Analysis | Hematopoietic stem cells | Stem cells
Journal Article
Blood, ISSN 0006-4971, 11/1992, Volume 80, Issue 10, pp. 2458 - 2462
Seven patients were treated with recombinant human tissue plasminogen activator (tPA) for severe hepatic venocclusive disease (VOD) that developed after bone...
Recombinant Proteins - therapeutic use | Hepatic Veno-Occlusive Disease - etiology | Humans | Middle Aged | Heparin - therapeutic use | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - administration & dosage | Bilirubin - blood | Thrombolytic Therapy | Bone Marrow Transplantation - adverse effects | Adult | Hepatic Veno-Occlusive Disease - drug therapy
Recombinant Proteins - therapeutic use | Hepatic Veno-Occlusive Disease - etiology | Humans | Middle Aged | Heparin - therapeutic use | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - therapeutic use | Recombinant Proteins - administration & dosage | Bilirubin - blood | Thrombolytic Therapy | Bone Marrow Transplantation - adverse effects | Adult | Hepatic Veno-Occlusive Disease - drug therapy
Journal Article
Blood, ISSN 0006-4971, 1993, Volume 81, Issue 12, pp. 3458 - 3462
Venocclusive disease (VOD) of the liver is the major dose-limiting complication of pretransplant regimens for bone marrow transplantation. Recent reports from...
Lymphoma - surgery | Multivariate Analysis | Humans | Middle Aged | Risk Factors | Factor VII - metabolism | Male | Hepatic Veno-Occlusive Disease - blood | Protein S - metabolism | Hemostasis | Adolescent | Blood Coagulation | Bone Marrow Transplantation - adverse effects | Adult | Female | Leukemia - surgery | Kinetics | Protein C - metabolism
Lymphoma - surgery | Multivariate Analysis | Humans | Middle Aged | Risk Factors | Factor VII - metabolism | Male | Hepatic Veno-Occlusive Disease - blood | Protein S - metabolism | Hemostasis | Adolescent | Blood Coagulation | Bone Marrow Transplantation - adverse effects | Adult | Female | Leukemia - surgery | Kinetics | Protein C - metabolism
Journal Article
Expert Review of Gastroenterology & Hepatology, ISSN 1747-4124, 05/2019, Volume 13, Issue 5, pp. 463 - 484
Introduction: Veno-occlusive-disease (VOD), known also as sinusoidal-obstruction-syndrome (SOS), is one of the main complications of haematopoietic stem cell...
Hepatic veno-occlusive diseases | computed tomography | hepatic venous pressure gradient | fibroscan | ultrasonography: review: magnetic resonance | nuclear medicine | sinusoidal obstruction syndrome | elastography | ultrasound | VENOCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | TRANSIENT ELASTOGRAPHY | SONOGRAPHIC DIAGNOSIS | NEOADJUVANT CHEMOTHERAPY | CONTRAST-ENHANCED CT | INTRAHEPATIC PORTOSYSTEMIC SHUNT | STEM-CELL TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | PORTAL-HYPERTENSION
Hepatic veno-occlusive diseases | computed tomography | hepatic venous pressure gradient | fibroscan | ultrasonography: review: magnetic resonance | nuclear medicine | sinusoidal obstruction syndrome | elastography | ultrasound | VENOCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | TRANSIENT ELASTOGRAPHY | SONOGRAPHIC DIAGNOSIS | NEOADJUVANT CHEMOTHERAPY | CONTRAST-ENHANCED CT | INTRAHEPATIC PORTOSYSTEMIC SHUNT | STEM-CELL TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | PORTAL-HYPERTENSION
Journal Article
European Radiology, ISSN 0938-7994, 6/2018, Volume 28, Issue 6, pp. 2291 - 2298
To evaluate the predictive value of ultrasonography in children with clinically suspicious hepatic veno-occlusive disease (VOD) after hematopoietic stem cell...
Doppler ultrasonography | Medicine & Public Health | Diagnostic Radiology | Hepatic veno-occlusive disease | Internal Medicine | Complication | Interventional Radiology | Children | Imaging / Radiology | Ultrasound | Neuroradiology | Hematopoietic stem cell transplantation | VENOCCLUSIVE DISEASE | DIAGNOSIS | DOPPLER SONOGRAPHY | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | DUPLEX SONOGRAPHY | FOLLOW-UP | BLOOD-FLOW | ARTERIAL BUFFER RESPONSE | LIVER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Humans | Portal Vein - physiopathology | Child, Preschool | Hepatic Artery - physiopathology | Infant | Male | Edema - diagnostic imaging | Young Adult | Gallbladder Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Child | Gallbladder Diseases - diagnostic imaging | Ultrasonography - methods | Hepatic Veno-Occlusive Disease - diagnostic imaging | Ascites - etiology | Hepatic Veno-Occlusive Disease - etiology | Ultrasonography, Doppler, Color - methods | Ascites - diagnostic imaging | Portal Vein - diagnostic imaging | Disease Progression | Hepatic Veins - diagnostic imaging | Edema - etiology | Adolescent | Hepatic Artery - diagnostic imaging | Blood Flow Velocity - physiology | Dropsy | Edema | Ultrasound imaging | Stem cells | Development and progression | Transplantation | Diagnostic imaging | Ascites | Hematopoietic stem cells | Diseases | Hepatic artery | Splenomegaly | Liver diseases | Syngeneic grafts | Stem cell transplantation | Wall thickness | Doppler effect | Velocity | Hemopoiesis | Veno-occlusive disease | Reversed flow | Hepatic vein | Ultrasonography | Gallbladder | Diagnostic systems | Portal vein | Veins & arteries
Doppler ultrasonography | Medicine & Public Health | Diagnostic Radiology | Hepatic veno-occlusive disease | Internal Medicine | Complication | Interventional Radiology | Children | Imaging / Radiology | Ultrasound | Neuroradiology | Hematopoietic stem cell transplantation | VENOCCLUSIVE DISEASE | DIAGNOSIS | DOPPLER SONOGRAPHY | OCCLUSIVE DISEASE | BONE-MARROW-TRANSPLANTATION | DUPLEX SONOGRAPHY | FOLLOW-UP | BLOOD-FLOW | ARTERIAL BUFFER RESPONSE | LIVER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prognosis | Humans | Portal Vein - physiopathology | Child, Preschool | Hepatic Artery - physiopathology | Infant | Male | Edema - diagnostic imaging | Young Adult | Gallbladder Diseases - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Child | Gallbladder Diseases - diagnostic imaging | Ultrasonography - methods | Hepatic Veno-Occlusive Disease - diagnostic imaging | Ascites - etiology | Hepatic Veno-Occlusive Disease - etiology | Ultrasonography, Doppler, Color - methods | Ascites - diagnostic imaging | Portal Vein - diagnostic imaging | Disease Progression | Hepatic Veins - diagnostic imaging | Edema - etiology | Adolescent | Hepatic Artery - diagnostic imaging | Blood Flow Velocity - physiology | Dropsy | Edema | Ultrasound imaging | Stem cells | Development and progression | Transplantation | Diagnostic imaging | Ascites | Hematopoietic stem cells | Diseases | Hepatic artery | Splenomegaly | Liver diseases | Syngeneic grafts | Stem cell transplantation | Wall thickness | Doppler effect | Velocity | Hemopoiesis | Veno-occlusive disease | Reversed flow | Hepatic vein | Ultrasonography | Gallbladder | Diagnostic systems | Portal vein | Veins & arteries
Journal Article